Kiora (NASDAQ: KPRX) executive uses 929 shares to satisfy tax withholding

Rhea-AI Filing Summary

Kiora Pharmaceuticals Chief Development Officer Eric Joseph Daniels reported a tax-related share disposition. On the transaction date, 929 shares of Kiora Pharmaceuticals common stock were withheld at $1.95 per share to cover tax obligations. After this non-open-market tax-withholding disposition, Daniels directly held 31,741 shares of common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Daniels Eric Joseph

Role Chief Development Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	929	$1.95	$2K

Holdings After Transaction: Common Stock — 31,741 shares (Direct)

Footnotes (1)

Key Figures

Shares used for tax withholding: 929 shares Tax-withholding share price: $1.95 per share Shares held after transaction: 31,741 shares

3 metrics

Shares used for tax withholding 929 shares Tax-withholding disposition of common stock

Tax-withholding share price $1.95 per share Value used for 929-share tax disposition

Shares held after transaction 31,741 shares Direct common stock ownership after Form 4 event

Key Terms

tax-withholding disposition, Common Stock, non-derivative, Form 4

4 terms

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

""transaction_type": "non-derivative""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Daniels Eric Joseph

(Last) (First) (Middle)

C/O KIORA PHARMACEUTICALS, INC.

169 SAXONY RD., SUITE 212

(Street)

ENCINITAS CALIFORNIA 92024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KIORA PHARMACEUTICALS INC [ KPRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Development Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		F		929	D	$1.95	31,741	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Net share settlement, shares withheld for employee tax obligation upon vesting of restricted stock.

	/s/ Melissa Tosca, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did KPRX officer Eric Joseph Daniels report in this Form 4?

Eric Joseph Daniels reported a tax-withholding disposition of Kiora Pharmaceuticals shares. The filing shows 929 shares of common stock were delivered to satisfy tax obligations, rather than sold on the open market, and he continued to hold 31,741 shares afterward.

How many KPRX shares were used for tax withholding by Eric Joseph Daniels?

Eric Joseph Daniels used 929 Kiora Pharmaceuticals shares to cover taxes. These common shares were valued at $1.95 per share for the tax-withholding disposition, according to the Form 4, and did not represent an open-market sale transaction.

Is the KPRX Form 4 a market sale or tax-withholding event?

The KPRX Form 4 reflects a tax-withholding event, not a market sale. Code F indicates payment of tax liability by delivering securities, meaning shares were withheld by the issuer rather than sold through open-market trading.

How many KPRX shares does Eric Joseph Daniels hold after this Form 4 transaction?

After the tax-withholding disposition, Daniels directly holds 31,741 Kiora shares. This remaining position in common stock is reported in the Form 4 as his direct ownership following the 929-share tax-withholding event.

What does transaction code F mean in the KPRX Form 4 filing?

Transaction code F indicates a tax-withholding disposition of shares. In this Kiora Pharmaceuticals Form 4, it reflects payment of a tax liability by delivering 929 common shares, rather than executing a standard open-market buy or sell trade.